Moreover, genomic deletions of 5’-exons have been described in patients with neurodevelopmental disorders, and an aberrant gene fusion of 5’-PAX5 and 3’-AUTS2 in B-ALL patients results in losses of anterior parts of AUTS2 protein [46–49]. This evidence concerns the gene AUTS2 and precursor B-cell acute lymphoblastic leukemia.